Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations

Pedro Piccardo, Juris J. Liepnieks, Albert William, Stephen Dlouhy, Martin Farlow, Katherine Young, David Nochlin, Thomas D. Bird, Randal R. Nixon, Melvyn J. Ball, Charles DeCarli, Orso Bugiani, Fabrizio Tagliavini, Merrill Benson, Bernardino Ghetti

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Gerstmann-Sträussler-Scheinker disease (GSS) is characterized by the accumulation of proteinase K (PK)-resistant prion protein fragments (PrPsc) of ∼7 to 15 kd in the brain. Purified GSS amyloid is composed primarily of ∼7-kd PrP peptides, whose N terminus corresponds to residues W81 and G88 to G90 in patients with the A117V mutation and to residue W81 in patients with the F198S mutation. The aim of this study was to characterize PrP in brain extracts, microsomal preparations, and purified fractions from A117V patients and to determine the N terminus of PrPsc species in both GSS A117V and F198S. In all GSS A117V patients, the ∼7-kd PrPsc fragment isolated from nondigested and PK-digested samples had the major N terminus at residue G88 and G90, respectively. Conversely, in all patients with GSS F198S, an ∼8-kd PrPsc fragment was isolated having the major N terminus start at residue G74. It is possible that a further degradation of this fragment generates the amyloid subunit starting at W81. The finding that patients with GSS A117V and F198S accumulate PrPsc fragments of different size and N-terminal sequence, suggests that these mutations generate two distinct PrP conformers.

Original languageEnglish
Pages (from-to)2201-2207
Number of pages7
JournalAmerican Journal of Pathology
Volume158
Issue number6
StatePublished - 2001

Fingerprint

Mutation
Endopeptidase K
Amyloid
Brain
Prion Proteins
Peptides

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. / Piccardo, Pedro; Liepnieks, Juris J.; William, Albert; Dlouhy, Stephen; Farlow, Martin; Young, Katherine; Nochlin, David; Bird, Thomas D.; Nixon, Randal R.; Ball, Melvyn J.; DeCarli, Charles; Bugiani, Orso; Tagliavini, Fabrizio; Benson, Merrill; Ghetti, Bernardino.

In: American Journal of Pathology, Vol. 158, No. 6, 2001, p. 2201-2207.

Research output: Contribution to journalArticle

Piccardo, P, Liepnieks, JJ, William, A, Dlouhy, S, Farlow, M, Young, K, Nochlin, D, Bird, TD, Nixon, RR, Ball, MJ, DeCarli, C, Bugiani, O, Tagliavini, F, Benson, M & Ghetti, B 2001, 'Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations', American Journal of Pathology, vol. 158, no. 6, pp. 2201-2207.
Piccardo, Pedro ; Liepnieks, Juris J. ; William, Albert ; Dlouhy, Stephen ; Farlow, Martin ; Young, Katherine ; Nochlin, David ; Bird, Thomas D. ; Nixon, Randal R. ; Ball, Melvyn J. ; DeCarli, Charles ; Bugiani, Orso ; Tagliavini, Fabrizio ; Benson, Merrill ; Ghetti, Bernardino. / Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. In: American Journal of Pathology. 2001 ; Vol. 158, No. 6. pp. 2201-2207.
@article{a0e171ff55b141a0a034130a2a04198e,
title = "Prion proteins with different conformations accumulate in Gerstmann-Str{\"a}ussler-Scheinker disease caused by A117V and F198S mutations",
abstract = "Gerstmann-Str{\"a}ussler-Scheinker disease (GSS) is characterized by the accumulation of proteinase K (PK)-resistant prion protein fragments (PrPsc) of ∼7 to 15 kd in the brain. Purified GSS amyloid is composed primarily of ∼7-kd PrP peptides, whose N terminus corresponds to residues W81 and G88 to G90 in patients with the A117V mutation and to residue W81 in patients with the F198S mutation. The aim of this study was to characterize PrP in brain extracts, microsomal preparations, and purified fractions from A117V patients and to determine the N terminus of PrPsc species in both GSS A117V and F198S. In all GSS A117V patients, the ∼7-kd PrPsc fragment isolated from nondigested and PK-digested samples had the major N terminus at residue G88 and G90, respectively. Conversely, in all patients with GSS F198S, an ∼8-kd PrPsc fragment was isolated having the major N terminus start at residue G74. It is possible that a further degradation of this fragment generates the amyloid subunit starting at W81. The finding that patients with GSS A117V and F198S accumulate PrPsc fragments of different size and N-terminal sequence, suggests that these mutations generate two distinct PrP conformers.",
author = "Pedro Piccardo and Liepnieks, {Juris J.} and Albert William and Stephen Dlouhy and Martin Farlow and Katherine Young and David Nochlin and Bird, {Thomas D.} and Nixon, {Randal R.} and Ball, {Melvyn J.} and Charles DeCarli and Orso Bugiani and Fabrizio Tagliavini and Merrill Benson and Bernardino Ghetti",
year = "2001",
language = "English",
volume = "158",
pages = "2201--2207",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations

AU - Piccardo, Pedro

AU - Liepnieks, Juris J.

AU - William, Albert

AU - Dlouhy, Stephen

AU - Farlow, Martin

AU - Young, Katherine

AU - Nochlin, David

AU - Bird, Thomas D.

AU - Nixon, Randal R.

AU - Ball, Melvyn J.

AU - DeCarli, Charles

AU - Bugiani, Orso

AU - Tagliavini, Fabrizio

AU - Benson, Merrill

AU - Ghetti, Bernardino

PY - 2001

Y1 - 2001

N2 - Gerstmann-Sträussler-Scheinker disease (GSS) is characterized by the accumulation of proteinase K (PK)-resistant prion protein fragments (PrPsc) of ∼7 to 15 kd in the brain. Purified GSS amyloid is composed primarily of ∼7-kd PrP peptides, whose N terminus corresponds to residues W81 and G88 to G90 in patients with the A117V mutation and to residue W81 in patients with the F198S mutation. The aim of this study was to characterize PrP in brain extracts, microsomal preparations, and purified fractions from A117V patients and to determine the N terminus of PrPsc species in both GSS A117V and F198S. In all GSS A117V patients, the ∼7-kd PrPsc fragment isolated from nondigested and PK-digested samples had the major N terminus at residue G88 and G90, respectively. Conversely, in all patients with GSS F198S, an ∼8-kd PrPsc fragment was isolated having the major N terminus start at residue G74. It is possible that a further degradation of this fragment generates the amyloid subunit starting at W81. The finding that patients with GSS A117V and F198S accumulate PrPsc fragments of different size and N-terminal sequence, suggests that these mutations generate two distinct PrP conformers.

AB - Gerstmann-Sträussler-Scheinker disease (GSS) is characterized by the accumulation of proteinase K (PK)-resistant prion protein fragments (PrPsc) of ∼7 to 15 kd in the brain. Purified GSS amyloid is composed primarily of ∼7-kd PrP peptides, whose N terminus corresponds to residues W81 and G88 to G90 in patients with the A117V mutation and to residue W81 in patients with the F198S mutation. The aim of this study was to characterize PrP in brain extracts, microsomal preparations, and purified fractions from A117V patients and to determine the N terminus of PrPsc species in both GSS A117V and F198S. In all GSS A117V patients, the ∼7-kd PrPsc fragment isolated from nondigested and PK-digested samples had the major N terminus at residue G88 and G90, respectively. Conversely, in all patients with GSS F198S, an ∼8-kd PrPsc fragment was isolated having the major N terminus start at residue G74. It is possible that a further degradation of this fragment generates the amyloid subunit starting at W81. The finding that patients with GSS A117V and F198S accumulate PrPsc fragments of different size and N-terminal sequence, suggests that these mutations generate two distinct PrP conformers.

UR - http://www.scopus.com/inward/record.url?scp=0034974318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034974318&partnerID=8YFLogxK

M3 - Article

C2 - 11395398

AN - SCOPUS:0034974318

VL - 158

SP - 2201

EP - 2207

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -